Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Unsatisfactory Response to Initial Αlpha1 Blocker Therapy: The SPLASH Study

Switching to silodosin is an effective and safe therapy in yielding relief from LUTS due to BPH and improving quality of life in patients with unsatisfactory treatment response to other alpha 1 blockers.